Wogonin could downregulate the expression of NRF2 as well as its target proteins HO-1, NADP(H), and NQO-1 to impair the NRF2-mediated antioxidant system and reverse DOX resistance in MCF-7ADR breast cancer cells [154]. The gene discussed is NFE2L2; the disease is breast carcinoma.